Heads of 4 MNCs were newly appointed last year… increase of
By Eo, Yun-Ho | translator Alice Kang
22.01.06 14:22:06
가나다라
0
Novartis·BI·Janssen appoints new head after term of office expiry… Organon is newly launched in Korea
Ratio of women CEOs reaches over 30% for the first time…GSK Consumer Healthcare’s lead yet vacant
▲(From the left) GMs Byungjae Yoo, Martin Corcoll, Cherry Huang, So Eun Kim
Four multinational pharmaceutical companies have appointed new CEOs over the past year.According to Dailypharm’s update of CEOs in 32 major multinational pharmaceutical companies, including the Korean Research-based Pharmaceutical Industry Association, heads of 4 pharmaceutical companies were replaced or newly appointed last year.
Most were regular personnel appointments mainly due to term of office expiry, with others due to CEO’s relocation or corporate spin-offs.
First, companies such as Novartis Korea, Boehringer Ingelheim, and Janssen Korea welcomed new
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)